M
Miłosz Jankowski
Researcher at Jagiellonian University Medical College
Publications - 39
Citations - 1411
Miłosz Jankowski is an academic researcher from Jagiellonian University Medical College. The author has contributed to research in topics: Population & Extracorporeal membrane oxygenation. The author has an hindex of 16, co-authored 35 publications receiving 1286 citations. Previous affiliations of Miłosz Jankowski include Jagiellonian University.
Papers
More filters
Journal ArticleDOI
Patient Values and Preferences in Decision Making for Antithrombotic Therapy: A Systematic Review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Samantha MacLean,Sohail M. Mulla,Elie A. Akl,Miłosz Jankowski,Per Olav Vandvik,Shanil Ebrahim,Shelley McLeod,Neera Bhatnagar,Gordon H. Guyatt +8 more
TL;DR: Patient values and preferences regarding thromboprophylaxis treatment appear to be highly variable and it should be standard for clinical practice guidelines to conduct systematic reviews of patient values and preference in the specific content area.
Journal ArticleDOI
Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia
TL;DR: In men with hypercholesterolemia simvastatin treatment lowers serum levels of CRP and proinflammatory cytokines, and low-dose aspirin does not add to the anti-inflammatory action of simVastatin.
Journal ArticleDOI
Risk Prediction Models for Mortality in Ambulatory Patients With Heart Failure A Systematic Review
Ana C. Alba,Thomas Agoritsas,Miłosz Jankowski,Delphine S. Courvoisier,Stephen D. Walter,Gordon Guyatt,Heather J. Ross +6 more
TL;DR: In this paper, the authors identified studies that evaluate the use of risk prediction models for mortality in ambulatory patients with heart failure and describe their performance and clinical applicability, and identified 34 studies testing 20 models.
Journal ArticleDOI
Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.
Andrzej Szczeklik,Jacek Musiał,Anetta Undas,Piotr Gajewski,P. F. Góra,Jakub Swadźba,Miłosz Jankowski +6 more
TL;DR: In men with hypercholesterolemia, lowering serum cholesterol level by a three-month simvastatin treatment is accompanied by a marked reduction of thrombin generation both at basal conditions in venous blood and after activation of hemostasis by microvascular injury.
Journal ArticleDOI
Plasma Homocysteine Affects Fibrin Clot Permeability and Resistance to Lysis in Human Subjects
Anetta Undas,Jan Brozek,Miłosz Jankowski,Zbigniew Siudak,Andrzej Szczeklik,Hieronim Jakubowski +5 more
TL;DR: The results indicate that plasma tHcy predicts clot permeation and susceptibility to fibrinolysis in healthy men and CAD patients, which is consistent with a mechanism of thrombosis in hyperhomocysteinemia, which involves modification of fibrinogen by Hcy–thiolactone.